Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia
- PMID: 26943037
- PMCID: PMC4991472
- DOI: 10.18632/oncotarget.7819
Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia
Abstract
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in the Western world, whereas in Asia the incidence is about 10 times lower. The basis for this ethnic and geographic variation is currently unknown. The aim of this study was to characterize IGHVDJ rearrangements and stereotype of the HCDR3 region in a series of 623 Chinese CLL, in order to identify possible differences in immunoglobulin gene usage and their potential pathogenetic implications. Chinese CLL were compared to 789 Italian CLL. Chinese patients showed a higher proportion of mutated IGHV and a more frequent usage of IGHV3-7, IGHV3-74, IGHV4-39 and IGHV4-59 genes. A significantly lower usage of IGHV1-69 and IGHV1-2 was documented, with comparable IGHV3-21 frequency (3% Chinese vs 3.8% Italian CLL). The proportion of known stereotyped receptors was significantly lower in Chinese (19.7%) than in Italian CLL (25.8%), despite a significantly higher frequency of subset #8 (p= 0.0001). Moreover, new paired clusters were identified among Chinese cases. Overall, these data support a potential different antigenic exposure between Eastern and Western CLL.
Keywords: Chinese CLL; IGHV; Italian CLL; chronic lymphocytic leukemia; stereotyped receptors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):447-457.e2. doi: 10.1016/j.clml.2013.02.019. Epub 2013 May 9. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23665144
-
Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):252-60. doi: 10.1016/j.clml.2012.03.005. Epub 2012 May 4. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22560084
-
Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.Cancer Sci. 2009 Dec;100(12):2346-53. doi: 10.1111/j.1349-7006.2009.01341.x. Epub 2009 Sep 2. Cancer Sci. 2009. PMID: 19824994 Free PMC article.
-
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.Br J Haematol. 2011 Apr;153(1):3-14. doi: 10.1111/j.1365-2141.2010.08440.x. Epub 2011 Feb 8. Br J Haematol. 2011. PMID: 21303354 Review.
-
[Biological characteristics and clinical significance of stereotyped B-cell receptor in chronic lymphocytic leukemia].Zhonghua Xue Ye Xue Za Zhi. 2024 Feb 14;45(2):197-202. doi: 10.3760/cma.j.cn121090-20230718-00012. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 38604800 Free PMC article. Review. Chinese.
Cited by
-
98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.Cancer Med. 2020 Feb;9(3):999-1007. doi: 10.1002/cam4.2788. Epub 2019 Dec 17. Cancer Med. 2020. PMID: 31849198 Free PMC article.
-
IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile.Front Oncol. 2022 Jun 2;12:858523. doi: 10.3389/fonc.2022.858523. eCollection 2022. Front Oncol. 2022. PMID: 35720006 Free PMC article.
-
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.Front Immunol. 2023 Jul 7;14:1184395. doi: 10.3389/fimmu.2023.1184395. eCollection 2023. Front Immunol. 2023. PMID: 37483630 Free PMC article.
-
[Distinguish immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Chinese patients with chronic lymphocytic leukemia].Zhonghua Xue Ye Xue Za Zhi. 2021 Dec 14;42(12):1025-1029. doi: 10.3760/cma.j.issn.0253-2727.2021.12.011. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 35045675 Free PMC article. Chinese. No abstract available.
-
Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.Cancer Res Treat. 2020 Jan;52(1):189-206. doi: 10.4143/crt.2019.122. Epub 2019 Jul 1. Cancer Res Treat. 2020. PMID: 31291713 Free PMC article.
References
-
- Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. The New England Journal of Medicine. 2005;352:804–815. - PubMed
-
- Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848–1854. - PubMed
-
- Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840–1847. - PubMed
-
- Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, Tamburini A, Suppo G, Battaglia A, Del Principe MI, Del Moro B, Masi M, Amadori S. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood. 2001;98:2633–2639. - PubMed
-
- Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. The New England Journal of Medicine. 2003;348:1764–1775. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources